Skip to main content
S 2215 103th Congress Senate

Biomaterials Access Assurance Act of 1994

Official title: A bill to establish rules governing product liability actions against raw materials and bulk component suppliers to medical device manufacturers, and for other purposes.

Introduced: July 29, 1994 See on congress.gov
Commerce Administrative procedureArtificial implantsBiomedical engineeringBiomedical materials
More subjectsShow fewer subjects
Civil actions and liabilityDepartment of Health and Human ServicesEvidence (Law)Federal preemptionGovernment Operations and PoliticsHealthLawManufacturing industriesMaterialsMedical suppliesProducts liabilityRaw materialsScience, Technology, CommunicationsState laws
Sign in to write a letter Sign in to watch
This bill died when the 103rd Congress ended
It never became law before the 103rd Congress (1993–1994) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 20, 1994
Read twice and referred to the Committee on Commerce.
Jun 20, 1994
Introduced in Senate
Jun 20, 1994
Sponsor introductory remarks on measure. (CR S7153-7154)
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action June 20, 1994

Read twice and referred to the Committee on Commerce.

 Plain-English summary Congressional Research Service

Biomaterials Access Assurance Act of 1994 - Declares that this Act applies to any civil action brought in either State or Federal court against a manufacturer, seller, or biomaterials supplier, or against a licensor of such suppliers for harm caused by an implant.

Prescribes procedural guidelines and the burden of proof for actions against biomaterials suppliers for harm caused by an implant. Precludes such actions, except as provided under this Act, against a person who has neither registered with the Secretary of Health and Human Services nor included the implant on a list of devices filed pursuant to the Federal Food, Drug, and Cosmetic Act.

 Related & companion bills 1
  • HR 5092 Identical bill Biomaterials Access Assurance Act of 1994
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Republican 1
R
Grassley, Chuck
Iowa · Jul 29, 1994
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2215: Biomaterials Access Assurance Act of 1994. 103rd Congress. Open America. https://openamerica.io/bill/103-S-2215/
MLA
"S. 2215: Biomaterials Access Assurance Act of 1994." 103rd Congress, 2026, Open America, https://openamerica.io/bill/103-S-2215/.
Bluebook (legal)
S. 2215, 103rd Cong. (2026), https://openamerica.io/bill/103-S-2215/.
Markdown link
[S. 2215: Biomaterials Access Assurance Act of 1994](https://openamerica.io/bill/103-S-2215/)
Report a problem